Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 352

    1.

    Significance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patients.

    Prucha M, Herold I, Zazula R, Dubska L, Dostal M, Hildebrand T, Hyanek J.

    Crit Care. 2003 Dec;7(6):R154-9. Epub 2003 Oct 1.PMID: 14624690 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?

    Sakr Y, Burgett U, Nacul FE, Reinhart K, Brunkhorst F.

    Crit Care Med. 2008 Jul;36(7):2014-22.PMID: 18552695 [PubMed - indexed for MEDLINE]Related articles

    3.

    Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein.

    Pavcnik-Arnol M, Hojker S, Derganc M.

    Intensive Care Med. 2004 Jul;30(7):1454-60. Epub 2004 May 4.PMID: 15127192 [PubMed - indexed for MEDLINE]Related articles

    4.

    Lipopolysaccharide-binding protein (LBP) and markers of acute-phase response in patients with multiple organ dysfunction syndrome (MODS) following open heart surgery.

    Sablotzki A, Börgermann J, Baulig W, Friedrich I, Spillner J, Silber RE, Czeslick E.

    Thorac Cardiovasc Surg. 2001 Oct;49(5):273-8.PMID: 11605136 [PubMed - indexed for MEDLINE]Related articles

    5.

    Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.

    Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R.

    Intensive Care Med. 2000 Mar;26 Suppl 2:S148-52.PMID: 18470710 [PubMed - indexed for MEDLINE]Related articles

    7.

    Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6.

    Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Köhl J.

    Crit Care Med. 2000 Aug;28(8):2793-8.PMID: 10966252 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome]

    Liu XL, Du B, Pan JQ, Xu Y, Hua BL.

    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Feb;27(1):48-52. Chinese. PMID: 15782493 [PubMed - indexed for MEDLINE]Related articles

    9.

    Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock.

    Clec'h C, Fosse JP, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y.

    Crit Care Med. 2006 Jan;34(1):102-7.PMID: 16374163 [PubMed - indexed for MEDLINE]Related articles

    10.

    High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes.

    Zweigner J, Gramm HJ, Singer OC, Wegscheider K, Schumann RR.

    Blood. 2001 Dec 15;98(13):3800-8.PMID: 11739189 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Serum lipopolysaccharide-binding protein concentrations in trauma victims.

    Cunningham SC, Malone DL, Bochicchio GV, Genuit T, Keledjian K, Tracy JK, Napolitano LM.

    Surg Infect (Larchmt). 2006 Jun;7(3):251-61.PMID: 16875458 [PubMed - indexed for MEDLINE]Related articles

    12.

    Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children.

    Pavcnik-Arnol M, Hojker S, Derganc M.

    Intensive Care Med. 2007 Jun;33(6):1025-32. Epub 2007 Apr 5.PMID: 17410342 [PubMed - indexed for MEDLINE]Related articles

    13.

    Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock.

    Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH.

    J Infect Dis. 1999 Nov;180(5):1584-9.PMID: 10515819 [PubMed - indexed for MEDLINE]Related articles

    14.
    15.

    Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.

    Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L.

    Crit Care. 2004 Aug;8(4):R234-42. Epub 2004 Jun 10.PMID: 15312223 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit.

    BalcI C, Sungurtekin H, Gürses E, Sungurtekin U, Kaptanoglu B.

    Crit Care. 2003 Feb;7(1):85-90. Epub 2002 Oct 30.PMID: 12617745 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    [Comparison of procalcitonin, interleukin-6 and C-reactive protein in the differential diagnosis of patients with sepsis syndrome in intensive care units]

    Průcha M, Herold I, Zazula R, Dubská L, Kavka B, Dostál M.

    Vnitr Lek. 2003 Jul;49(7):541-7. Czech. PMID: 12931436 [PubMed - indexed for MEDLINE]Related articles

    18.

    Plasma procalcitonin in sepsis and organ failure.

    Yukioka H, Yoshida G, Kurita S, Kato N.

    Ann Acad Med Singapore. 2001 Sep;30(5):528-31.PMID: 11603140 [PubMed - indexed for MEDLINE]Related articles

    19.

    Reliability of procalcitonin as a severity marker in critically ill patients with inflammatory response.

    Tugrul S, Esen F, Celebi S, Ozcan PE, Akinci O, Cakar N, Telci L.

    Anaesth Intensive Care. 2002 Dec;30(6):747-54.PMID: 12500512 [PubMed - indexed for MEDLINE]Related articles

    20.

    Diagnostic and prognostic value of procalcitonin in patients with septic shock.

    Clec'h C, Ferriere F, Karoubi P, Fosse JP, Cupa M, Hoang P, Cohen Y.

    Crit Care Med. 2004 May;32(5):1166-9.PMID: 15190968 [PubMed - indexed for MEDLINE]Related articles